Automated Insulin Delivery Reduces Overnight Diabetes Management by Caregivers While Improving Nocturnal Glycemic Control in Young Children With Type 1 Diabetes - Report - MDSpire
Clinical Report: Automated Insulin Delivery Enhances Overnight Glycemic Control
Overview
This study evaluates the impact of automated insulin delivery on glycemic control in young children with type 1 diabetes, highlighting significant improvements in insulin delivery patterns. The findings indicate changes in nighttime glucose fluctuations in this population.
Background
Managing type 1 diabetes in very young children is particularly challenging due to fluctuating insulin requirements and the risk of hypoglycemia, especially during nighttime. The dusk phenomenon complicates insulin-dose planning, often disrupting parental sleep. Automated insulin delivery systems have shown promise in improving glycemic control, yet detailed insights into their effectiveness during critical nighttime periods remain limited.
Data Highlights
Measure
Baseline
Study Phase
P-value
Total Daily Dose (TDD)
13.3 IU/day
16.2 IU/day
< 0.001
TDD/kg
0.66
0.69
0.038
Insulin-to-Carbohydrate Ratio (Lunch)
22.3
25.3
Not reported
Key Findings
Mean participant age was 4.39 years with an HbA1c of 7.36% at baseline.
Total daily insulin dose increased significantly from 13.3 IU/day to 16.2 IU/day (p < 0.001).
User-initiated correction boluses decreased significantly during the dusk interval (20:00–24:00).
Automatically delivered insulin increased during the dusk interval, although average glucose levels remained unchanged.
From 00:00 to 05:00, total and basal insulin delivery patterns were also analyzed, showing notable changes.
Clinical Implications
The findings indicate that automated insulin delivery systems can enhance glycemic control during critical nighttime periods in young children with type 1 diabetes.
Conclusion
Automated insulin delivery systems demonstrate significant potential in managing overnight glycemic control in young children with type 1 diabetes.
More than 80% of women who were partially up to date reported a wellness visit in the prior year, suggesting missed opportunities for screening engagement in primary care.
In a pooled analysis of more than 1.5 million patients, sugar-sweetened beverages were associated with higher risks of HCC and ICC, while artificially-sweetened beverages showed no independent association with hepatic cancer.
